Nasdaq · Healthcare
SI-BONE, Inc. (SIBN)
As-reported financials and recent SEC filings for SI-BONE, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$200.9M
Net income
$-18.9M
Net margin
-9.4%
Diluted EPS
$-0.44
ROE
-10.6%
P/E (TTM)
—
Market cap
—
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $200.9M | $167.2M | $138.9M | $106.4M | $90.2M |
| Gross profit | $159.9M | $132.1M | $109.4M | $90.7M | $79.7M |
| Operating income | $-22.3M | $-35.2M | $-46.9M | $-59.6M | $-51.7M |
| Net income | $-18.9M | $-30.9M | $-43.3M | $-61.3M | $-56.6M |
| Diluted EPS | $-0.44 | $-0.75 | $-1.13 | $-1.79 | $-1.71 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-06-09
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →8-K2026-06-08
View on EDGAR →42026-06-08
View on EDGAR →Largest Healthcare peers
Go deeper on SIBN
Search SI-BONE, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.